Brief: Bio-Gene Technology Says MD& CEO Richard Jagger To Transition To Consultancy & Advisory
24/04/2023 02:34
April 24 (Reuters) - Bio-Gene Technology Ltd BGT.AX :
* MANAGING DIRECTOR & CEO RICHARD JAGGER TO TRANSITION FROM
FULL
TIME CEO ROLE TO AN ONGOING CONSULTANCY AND ADVISORY ROLE
Source text for Eikon: ID:nASX1xn0XN
Further company coverage: BGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio-Gene Technology
See all newsBrief: Bio-Gene Technology Receives Total Placement Commitments Of A$2.78 Million
Australia's Bio-Gene Technology slips to 4-1/2-month low on discounted placement
Brief: Bio-Gene Technology Ltd Raises A$3.21 MLN Via Placement, Partially Underwritten Share Purchase Plan
Brief: Bio-Gene Technology Seeks Trading Halt
Australia's Bio‑Gene surges on Asia expansion optimism for mosquito control products